CHEN Yan
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, China;Graduate School of Jinzhou Medical University, Jinzhou, Liaoning 121000, ChinaXU Qing
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, ChinaZHOU Qingzhi
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, ChinaCHEN Shengyue
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, ChinaLYU Zhibo
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, ChinaZHAO Xin
Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, China1.Department of Cardiovascular Medicine, the Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116027, China;2.Graduate School of Jinzhou Medical University, Jinzhou, Liaoning 121000, China)
R5
CHEN Yan, XU Qing, ZHOU Qingzhi, CHEN Shengyue, LYU Zhibo, ZHAO Xin. Research status of remnant cholesterol and cardiovascular disease risk[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(7):640-644.
Copy